Zhang Xingcai, Hai Luo, Gao Yibo, Yu Guocan, Sun Yingli
School of Engineering and Applied Sciences, Harvard University, Cambridge 02138, MA, USA.
Central Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
Acta Pharm Sin B. 2023 Mar;13(3):903-915. doi: 10.1016/j.apsb.2022.10.004. Epub 2022 Oct 11.
We summarize the most important advances in RNA delivery and nanomedicine. We describe lipid nanoparticle-based RNA therapeutics and the impacts on the development of novel drugs. The fundamental properties of the key RNA members are described. We introduced recent advances in the nanoparticles to deliver RNA to defined targets, with a focus on lipid nanoparticles (LNPs). We review recent advances in biomedical therapy based on RNA drug delivery and state-of-the-art RNA application platforms, including the treatment of different types of cancer. This review presents an overview of current LNPs based RNA therapies in cancer treatment and provides deep insight into the development of future nanomedicines sophisticatedly combining the unparalleled functions of RNA therapeutics and nanotechnology.
我们总结了RNA递送和纳米医学领域最重要的进展。我们描述了基于脂质纳米颗粒的RNA疗法及其对新型药物开发的影响。阐述了关键RNA成员的基本特性。我们介绍了在将RNA递送至特定靶点的纳米颗粒方面的最新进展,重点是脂质纳米颗粒(LNP)。我们回顾了基于RNA药物递送的生物医学治疗的最新进展以及最先进的RNA应用平台,包括不同类型癌症的治疗。本综述概述了当前基于LNP的RNA疗法在癌症治疗中的应用,并深入洞察了未来纳米医学的发展,这种发展巧妙地结合了RNA疗法和纳米技术无与伦比的功能。